https://www.thebodypro.com/tag/people-who-use-drugs

People Who Use Drugs

The Latest

dapivirine vaginal ring

This Week in HIV Research: Where the Rubber Meets the Ring

Sept. 10, 2020: Concomitant use of vaginal rings with condoms; benefits of more frequent HIV screening for young MSM; Black MSM, substance use, and the PrEP continuum; HIV outcomes stratified by anti-LGTBQ policy across U.S. states.

By Barbara Jungwirth and Myles Helfand
Annette Gaudino and Bryn Gay

With Several Curative Therapies for Hepatitis C on the Market, the Research Pipeline for Prevention Continues

The authors of an influential annual report on hepatitis C research and development talk through what's new and evolving in clinical science.

By Terri Wilder, M.S.W.
links in chain

This Week in HIV Research: Links in a Chain

July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?

By Barbara Jungwirth and Myles Helfand
counseling

Holistic Care Pays Dividends in Managing HIV, Study Finds

It’s more than just HIV, but comprehensive care systems aren’t as available as they should be.

By Larry Buhl
long road ahead

This Week in HIV Research: Do As We Say, Not As We Do

July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.

By Barbara Jungwirth and Myles Helfand
bridging the chasm

This Week in HIV Research: Closing Our Care Chasms

June 25, 2020: 25 years of HOPS; successes of San Francisco’s test-and-treat program; missed opportunities to test people who inject drugs; how patient-provider trust can curb prescribing cascades.

By Barbara Jungwirth and Myles Helfand
Suraj Madoori, M.P.H., M.S.J., M.A. and Annette Gaudino

Will We Ever Have a Hepatitis C Vaccine? Two Activists Weigh in on the Challenges and Opportunities Ahead

A new injection of funding from Congress could be the catalyst for a future hepatitis C (HCV) vaccine.

By Terri Wilder, M.S.W.
raising the bar

This Week in HIV Research: Setting a New Bar

June 11, 2020: Diagnosis rates within a year of infection; rates of intentional non-daily PrEP use; neurological development in children of birth parents with HIV; point-of-care urine test to assess tenofovir levels.

By Barbara Jungwirth and Myles Helfand
snowball

This Week in HIV Research: HIV/COVID-19 Case Studies Gain Momentum

June 4, 2020: The latest on COVID-19 hospitalization among people with HIV; real-world success of hepatitis C treatment in coinfected patients with good health care; poverty and adherence in Canada's health system; demographic and socioeconomic factors associated with viral rebound.

By Barbara Jungwirth and Myles Helfand
Natalia Linos headshot.

How to End COVID-19 and Other Pandemics With a Human Rights and Health Justice Approach

Natalia Linos, Sc.D., M.Sc., of Harvard University’s FXB Center for Health and Human Rights, calls for protections for low-wage essential workers and releasing people from jails, prisons, and ICE detention.

By Terri Wilder, M.S.W.